NCT05667441Completed
Adherence to Lifestyle Changes for Age-related Macular Degeneration
Source: ClinicalTrials.gov · Last updated 11 Sept 2025
Brief summary (registry, in English)
The AMD-Life study investigates which strategies (personalized risk-profiling including genetic testing and/or coaching) motivate AMD patients to change their lifestyle.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 150 (actual)
- First submitted
- 21 Nov 2022
- Start date
- 1 Aug 2021
- Primary completion date
- 14 Jul 2025
- Lead sponsor
- Erasmus Medical Center
- Diseases
- Macular degeneration
- NCT number
- NCT05667441
What you commit to
- Study type: Interventional
- Participants enrolled: 150
- From 1 Aug 2021 to the primary completion date, 14 Jul 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Diagnosis of dementia (because of unreliable dietary recall)
- Persons diagnosed with liver and kidney insufficiency.
Other
- Participation in other intervention studies for AMD
- Living in retirement homes (difficulty in implementation of diet)
- Persons with macular pathology other than AMD hindering appropriate grading of the macula
- Persons who are illiterate and have no independent trusted person with them to explain the informed consent form.
Who the study is looking for
- Early/Intermediate AMD or unilateral late AMD with minimal vision 0.8
Age in the registry: 55 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Erasmus Medical Center Coordinator of this site? Confirm its status | Rotterdam | Netherlands | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.